Exane Derivatives Pfizer Inc Transaction History

Exane Derivatives

$157 Million
Q2 2022

A detailed history of Exane Derivatives transactions in Pfizer Inc stock. As of the latest transaction made, Exane Derivatives holds 13,531 shares of PFE stock, worth $386,445. This represents 0.45% of its overall portfolio holdings.

Number of Shares

13,531

Previous 21,316 36.52%

Holding current value

$386,445

Previous $1.1 Million 35.72%

% of portfolio

0.45%

Previous 0.34%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 12, 2022	SELL	$46.53 - $55.17 $362,236 - $429,498	-7,785 Reduced 36.52%	13,531 $709,000
Q1 2022 Apr 22, 2022	SELL	$45.75 - $56.69 $37,469 - $46,429	-819 Reduced 3.7%	21,316 $1.1 Million
Q4 2021 Jan 28, 2022	BUY	$41.32 - $61.25 $97,556 - $144,611	2,361 Added 11.94%	22,135 $1.31 Million
Q3 2021 Oct 26, 2021	SELL	$39.25 - $50.42 $448,823 - $576,552	-11,435 Reduced 36.64%	19,774 $850,000
Q2 2021 Jul 28, 2021	SELL	$35.91 - $40.68 $420,182 - $475,996	-11,701 Reduced 27.27%	31,209 $1.22 Million
Q1 2021 Apr 30, 2021	BUY	$33.49 - $37.77 $473,280 - $533,765	14,132 Added 49.11%	42,910 $1.55 Million
Q4 2020 Jan 27, 2021	BUY	$33.47 - $42.56 $661,233 - $840,815	19,756 Added 218.98%	28,778 $1.06 Million
Q3 2020 Oct 06, 2020	SELL	$31.75 - $37.25 $32,321 - $37,920	-1,018 Reduced 10.14%	9,022 $314,000
Q2 2020 Jul 10, 2020	SELL	$30.12 - $36.54 $87,829 - $106,550	-2,916 Reduced 22.51%	10,040 $311,000
Q1 2020 Apr 17, 2020	SELL	$27.03 - $38.62 $36,977 - $52,832	-1,368 Reduced 9.55%	12,956 $401,000
Q4 2019 Jan 22, 2020	SELL	$32.92 - $37.36 $135,893 - $154,222	-4,128 Reduced 22.37%	14,324 $532,000
Q3 2019 Oct 15, 2019	BUY	$32.49 - $42.13 $599,505 - $777,382	18,452 New	18,452 $629,000
Q4 2018 Jan 31, 2019	SELL	$38.47 - $43.86 $1.25 Million - $1.43 Million	-32,514 Closed	0 $0
Q3 2018 Oct 24, 2018	SELL	$34.47 - $41.81 $1.05 Million - $1.27 Million	-30,490 Reduced 48.39%	32,514 $0
Q1 2018 Apr 30, 2018	BUY	$31.91 - $37.02 $2.01 Million - $2.33 Million	63,004 New	63,004 $0

Others Institutions Holding PFE

# of Institutions

3,216

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $160B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.

Account

Exane Derivatives Pfizer Inc Transaction History